These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34454531)

  • 1. Calibrated automated thrombogram II: removing barriers for thrombin generation measurements.
    Giesen PLA; Gulpen AJW; van Oerle R; Ten Cate H; Nagy M; Spronk HMH
    Thromb J; 2021 Aug; 19(1):60. PubMed ID: 34454531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram.
    Helin TA; Lemponen M; Lassila R; Joutsi-Korhonen L
    Res Pract Thromb Haemost; 2021 Mar; 5(3):439-446. PubMed ID: 33870029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Two Thrombin Generation Methods, CAT and ST-Genesia, in Liver Transplant Patients.
    Roullet S; Labrouche S; Freyburger G
    Thromb Haemost; 2019 Jun; 119(6):899-905. PubMed ID: 31005063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct oral anticoagulant plasma levels and thrombin generation on ST Genesia system.
    Pfrepper C; Metze M; Siegemund A; Klöter T; Siegemund T; Petros S
    Res Pract Thromb Haemost; 2020 May; 4(4):619-627. PubMed ID: 32548561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months.
    Foulon-Pinto G; Jourdi G; Perrin J; Abdoul J; Paris G; Gouin-Thibault I; Curis E; Lecompte T; Siguret V
    Int J Lab Hematol; 2021 Aug; 43(4):821-830. PubMed ID: 33369212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of DOAC Stop for elimination of anticoagulants in the thrombin generation assay.
    Kopatz WF; Brinkman HJM; Meijers JCM
    Thromb Res; 2018 Oct; 170():97-101. PubMed ID: 30149286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of apixaban compared with rivaroxaban and dabigatran on thrombin generation assay.
    Wong PC; White A; Luettgen J
    Hosp Pract (1995); 2013 Feb; 41(1):19-25. PubMed ID: 23466964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application.
    Douxfils J; Morimont L; Bouvy C; de Saint-Hubert M; Devalet B; Devroye C; Dincq AS; Dogné JM; Guldenpfennig M; Baudar J; Larock AS; Lessire S; Mullier F
    J Thromb Haemost; 2019 Aug; 17(8):1273-1287. PubMed ID: 31063645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercoagulability (thrombin generation) in patients with cirrhosis is detected with ST-Genesia.
    Talon L; Sinegre T; Lecompte T; Pereira B; Massoulié S; Abergel A; Lebreton A
    J Thromb Haemost; 2020 Sep; 18(9):2177-2190. PubMed ID: 32558351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant Activity of Nucleic Acid Nanoparticles (NANPs) Assessed by Thrombin Generation Dynamics on a Fully Automated System.
    de Freitas Saito R; Barion BG; da Rocha TRF; Rolband A; Afonin KA; Chammas R
    Methods Mol Biol; 2023; 2709():319-332. PubMed ID: 37572292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticoagulant effect of dabigatran is reflected in the lag time and time-to-peak, but not in the endogenous thrombin potential or peak, of thrombin generation.
    Bloemen S; Zwaveling S; Douxfils J; Roest M; Kremers R; Mullier F
    Thromb Res; 2018 Nov; 171():160-166. PubMed ID: 30316961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the analyzer ST Genesia.
    Modi Omasombo N; Demulder A; Rozen L
    Ann Biol Clin (Paris); 2022 Mar; 80(2):148-155. PubMed ID: 35766075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-blood thrombin generation monitored with a calibrated automated thrombogram-based assay.
    Ninivaggi M; Apitz-Castro R; Dargaud Y; de Laat B; Hemker HC; Lindhout T
    Clin Chem; 2012 Aug; 58(8):1252-9. PubMed ID: 22665918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban.
    Herrmann R; Thom J; Wood A; Phillips M; Muhammad S; Baker R
    Thromb Haemost; 2014 May; 111(5):989-95. PubMed ID: 24352511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin generation measured by two platforms in patients with a bleeding tendency.
    Cornette M; Monteyne T; De Kesel PM; Devreese KMJ
    J Thromb Haemost; 2021 Jun; 19(6):1460-1471. PubMed ID: 33724649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation estimates the anticoagulation effect of direct oral anticoagulants with significant interindividual variability observed.
    Rigano J; Ng C; Nandurkar H; Ho P
    Blood Coagul Fibrinolysis; 2018 Mar; 29(2):148-154. PubMed ID: 29176379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation measured on ST Genesia, a new platform in the coagulation routine lab: Assessment of analytical and between-subject variation.
    Kristensen SR; Nybo J; Pedersen S
    Res Pract Thromb Haemost; 2022 Jan; 6(1):e12654. PubMed ID: 35128301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dabigatran in vitro on thrombin biomarkers by Calibrated Automated Thrombography in patients after ischemic stroke.
    Serebruany V; Sani Y; Lynch D; Schevchuck A; Svetlov S; Fong A; Thevathasan L; Hanley D
    J Thromb Thrombolysis; 2012 Jan; 33(1):22-7. PubMed ID: 22065286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the impact of instrument variation and automated software algorithms on the TGT in hemophilia and normalized plasma.
    Woodle SA; Shibeko AM; Lee TK; Ovanesov MV
    Thromb Res; 2013 Sep; 132(3):374-80. PubMed ID: 23953593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the thrombin generation assay in patients with antiphospholipid syndrome: A systematic review of the literature.
    Gehlen R; Vandevelde A; de Laat B; Devreese KMJ
    Front Cardiovasc Med; 2023; 10():1075121. PubMed ID: 37057100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.